Format

Send to

Choose Destination
See comment in PubMed Commons below
J Chin Med Assoc. 2013 Nov;76(11):599-605. doi: 10.1016/j.jcma.2013.07.007. Epub 2013 Aug 9.

Induced pluripotent stem cells and hepatic differentiation.

Author information

1
Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan, ROC; Division of Urology, Department of Surgery, Taipei Veterans General Hospital and Su-Ao/Yuan-Shan Branch, Yi-Lan, Taiwan, ROC.

Abstract

Induced pluripotent stem cells (iPSCs) are generated by reprogramming somatic cells to a pluripotent state by the introduction of specific factors. They can be generated from cells of different origins, such as fibroblasts, keratinocytes, hepatocytes, and blood. iPSCs are similar to embryonic stem cells (ESCs) in several aspects, such as morphology, expression of pluripotency markers, and the ability to develop teratoma that contains tissue from three germ layers. In addition, iPSCs can undergo tridermal differentiation, including hepatic specific lineages. Considering that iPSCs could be a source of hepatocyte regeneration, iPSC-based therapy has been widely implicated in the treatment of liver disease and hepatic regeneration. In the present review, we discuss the therapeutic potential of iPSCs in hepatic repair and focus on the clinical applications of iPSCs.

KEYWORDS:

hepatic repair; induced pluripotent stem cells

PMID:
23933345
DOI:
10.1016/j.jcma.2013.07.007
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center